cjc-1295 ipamorelin clinical trials body composition Peptide Therapy: Benefits & Safety CJC-1295 / Ipamorelin Body Composition

Typical Dosing Recommendations Ipamorelin: 100300 mcg per dose CJC-1295 with DAC: 12 mg per week (due to long half-life) Most users inject Ipamorelin 12x per day and CJC-1295 12x per week, depending on their goal (fat loss, muscle growth, recovery, etc.)

Fatigue or lethargy: A minority of users experience tiredness, sometimes related to altered sleep patterns during the adjustment period

Palli 5/A, I - 43121 Parma Tel: (+39) 0521 036 425 Fax: (+39) 0521 036 525 [email protected] www.efsa.europa.eu 1 Page 2 and 3: out

doi: 10.1016/j.mito.2017.12.001 53 DinizY

How Medical Monitoring Reduces Ipamorelin Risk Medical monitoring helps reduce risk by making sure peptide therapy is tied to a real treatment goal, appropriate dosing, safe sourcing, and follow-up review